Irish Fungal Society Annual Meeting 2024

The 2024 IFS annual conference was held on Wednesday and Thursday June 19th/20th 2024, in the School of Biological Sciences at Queen’s University Belfast. There were selected short talks from abstract submissions, a poster session and a conference dinner held in the Ulster Museum. See below for more details. For details of the 2023 meeting, click here.

The Irish Fungal Society annual meeting was supported by Gilead who provided funding. Their supported speaker was  Prof Gordon Ramage. Gilead has had no input into the content of the materials used at this meeting.

Gilead Sponsored Presentation:

Gordon Ramage: Fungal biofilms in human health and disease: implications for wound infections

Invited Presentations:

Jane Usher: A powerhouse of resistance: Candida glabrata.

Johannes Wagener: New insights into the mode of action of azole antifungals against Aspergillus fumigatus.

Grace Hoysted: The future has roots in the past: mycorrhizal fungi, our allies in the soil.

Paul Bowyer: Mould, Frankenstein & Air – The Mycobiome in Fungal Disease.

Jerry Reen: Never the twain should meet: bile mediated chronicity in fungal respiratory pathogens.

 

Oral presentations

1st Prize:

Padraig G. Heneghan: cyPhyRNA-seq as a Method to Identify tRNA Targets of Yeast Anticodon Nucleases.

Highly commended prize:

Wen Jun Lim: Specific members of the TLO gene family are required for Tac1-activated fluconazole and terbinafine resistance in Candida albicans

Highly commended prize:

Joy Clarke: Characterisation of the microbial population within the Agaricus bisporus casing layer and how it is impacted by crop cycle progression and biological treatment application.

Other oral presentations (in order of appearance):

Sreyashi Acharjee: Antifungal drug tolerance in Candida glabrata is modulated by the complex interdependence between strain and environmental determinants.

Matthieu Osborne: Evolutionary arms race between a yeast homing genetic element and its genomic target.

Glaucia Rigotto Caruso: Silver Nanoparticles produced by Epicoccum nigrum culture filtrate and their impact on Fusarium keratoplasticum proteome.

Jillian Scully: Saccharomyces eubayanus isolates from Ireland.

Sean Bergin: Genotypic and phenotypic diversity in a large-scale screen of Candida parapsilosis.

Xinyi Zhao: Optimising the detection of mycotoxins by gold nanoparticle-based lamina flow immunochromatographic strip test (LFIAs).

Aaron Curtis:  Characterisation of Aspergillus fumigatus secretome during sub-lethal infection of Galleria mellonella larvae.

 

Poster presentations:

1st Prize:

Caelainn McAloran: Probing the suitability of Candida glabrata lysine deacetylase, cg_RPD3, as a novel antifungal target through structure/ function analysis.

Highly commended prize:

Hadel Aljaeed: Investigating the contributions to cell function of the different Swi-Snf complex subunits in Saccharomyces cerevisiae.

Highly commended prize:

Aaron Curtis: Prolonged Subculturing of Aspergillus fumigatus on Galleria Extract Agar Results in Altered Virulence and Sensitivity to Antifungal Agents.

Other posters (in the order of the book of abstracts):

Marcia Regina von Zeska Kress: Assessing Antifungal Resistance Mechanisms in Fusarium Species: Insights from cyp51A Gene Analysis and Expression Profiling.

Michael Pitts: Screen for triazole resistant Aspergillus fumigatus in foodstuffs and hospital campus air.

Steve Patmore: All-cause and attributable mortality in invasive candidiasis and/or candidaemia with rezafungin and caspofungin treatment: outcomes from the ReSTORE trial.

Steve Patmore: Safety outcomes with rezafungin and caspofungin in the treatment of candidaemia and/or invasive candidiasis: Phase 3 data from the ReSTORE trial.

Reham Hussain Alnajjar: Investigating the roles of Hho1p and Hmo1p during stationary phase in Saccharomyces cerevisiae.

Wen Jun Lim: Specific Mediator tail components, Med2 and Med15, are required for C. auris aggregation via regulating Scf1 adhesin and other putative adhesins.

Jessica Allison: From Crops to Clinic – The Dual Use of Azole Drugs in Promoting Cross-Resistance in Human Pathogenic Candida species.